LSV Asset Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$19.3M Buy
5,868,895
+712,184
+14% +$2.37M 0.04% 341
2026
Q2
$14.9M Buy
5,156,711
+174,780
+4% +$444K 0.03% 377
2026
Q1
$9.8M Buy
4,981,931
+2,156,031
+76% +$5.06M 0.02% 398
2025
Q4
$7.66M Buy
2,825,900
+471,319
+20% +$1.55M 0.02% 427
2025
Q3
$10M Buy
2,354,581
+1,973,017
+517% +$8.67M 0.02% 400
2025
Q2
$1.9M Buy
+381,564
New +$1.66M ﹤0.01% 561

Other funds holding GDRX

LSV Asset Management's GDRX Position: Q3 2026 in Review

LSV Asset Management increased its GoodRx Holdings (GDRX) stake by 14% in Q3 2026, buying an estimated $2.37M and bringing the position to 5,868,895 shares worth $19.3M. The position accounts for 0.04% of the portfolio, ranked #341.

LSV Asset Management first reported a position in GDRX in Q2 2025 and has held it in 6 quarters since. 69 funds tracked by Wall St. Rank hold GDRX as of Q3 2026.

  • LSV Asset Management held 5,868,895 shares of GoodRx Holdings worth $19.3M as of Q3 2026.
  • LSV Asset Management bought 712,184 GoodRx Holdings shares in Q3 2026, an estimated $2.37M.
  • GoodRx Holdings made up 0.04% of LSV Asset Management's portfolio in Q3 2026, its #341 holding.
  • LSV Asset Management first reported a position in GoodRx Holdings in Q2 2025 and has held it in 6 quarters since.
  • 69 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2026.

Based on LSV Asset Management's 13F filing for Q3 2026, filed 6 Nov 2026.